Nivam Orthopaedics Partners with Surya Hospitals to Establish Specialised Orthopaedic Centres in Mumbai

Nivam Orthopaedics Partners with Surya Hospitals to Establish Specialised Orthopaedic Centres in Mumbai

The centres will open at Surya Hospitals in key areas across Mumbai, expanding access to coordinated orthopaedic care within Surya’s existing network. Patients will inaugurate the centres.

Mumbai, 20th October 2026: Nivam Orthopaedics, founded by orthopaedic surgeons Dr. Nilen Shah and Dr. Manan Shah has partnered with Surya Hospitals to establish a network of specialised orthopaedic centres across Mumbai. The centres at Santacruz and Chembur are already operational, with the flagship Santacruz facility set to be formally inaugurated on Dussehra.

Designed to provide comprehensive, patient-centric care, the centres combine modern medical technology with access to orthopaedic specialists. The network will expand further with a centre in Kandivali, expected to be operational by the end of the year, followed by a facility in South Mumbai.

The collaboration combines Nivam’s focused orthopaedic expertise with Surya Hospitals’ established clinical infrastructure and multidisciplinary capabilities. The centres will offer care for joint conditions, spine disorders, sports injuries and orthopaedic trauma, including primary and complex joint replacement, revision procedures, and robotic-assisted and minimally invasive surgery.

Care will extend across the patient journey, from assessment and treatment planning to surgery, peri-operative care, physiotherapy and rehabilitation. Following thorough assessment, surgery will be offered only to those patients who clinically require it; the centres will also maintain strong departments for non-surgical care. Treatment options will be guided by individual clinical needs, with an emphasis on appropriate patient selection, safety and recovery.

Building on Surya’s Multidisciplinary Strengths

Dr Nilen Shah and Dr Manan Shah developed Nivam Orthopaedics to integrate surgical experience, technology and rehabilitation within a coordinated model of orthopaedic care. Dr. Nilen Shah has practised joint replacement surgery since the 1990s, while Dr. Manan Shah has contributed to the platform’s technology-supported approach. These centres will operate as part of Surya Hospitals’ broader clinical ecosystem, complementing the care already provided across the network.

Dr. Bhupendra S. Avasthi, Founder, Chairman and Managing Director, Surya Hospitals, said, “Our partnership with Nivam Orthopaedics brings additional specialised orthopaedic expertise to Surya locations across Mumbai. Surya has long been established for paediatric orthopaedic work, and with women accounting for nearly 80 percent of joint and orthopaedic problems including joint replacement, this is a natural extension of our specialty services. Dr. Nilen Shah and Dr. Manan Shah have developed a focused model of joint replacement and comprehensive orthopaedic care. Together, we aim to make these services more accessible within our hospitals and to support patients through every stage of treatment and recovery.”

Dr. Nilen Shah, Founder, Nivam Orthopaedics, said, “Nivam was built on the belief that orthopaedic care should combine sound clinical judgement, appropriate technology and a clear recovery plan. Establishing our centres with Surya Hospitals allows patients across Mumbai to access this coordinated approach, supported by teams that can guide them from diagnosis through treatment and rehabilitation. We are pleased to begin this journey with patients at the heart of the centres’ inauguration.”

Dr. Manan Shah, Consultant Orthopaedic and Joint Replacement Surgeon, Nivam Orthopaedics said, “Technology is central to improving surgical precision and patient outcomes. Supported by state-of-the-art infrastructure and an ethos of coordinated, patient-focused care, these centres are designed to help people return to the lives they want to lead.”

Paras Healthcare Limited’s Initial Public Offer to open on Wednesday, October 21, 2026

Paras Healthcare Limited’s Initial Public Offer to open on Wednesday, October 21, 2026

Price Band has been fixed at ₹ 660 to ₹ 693 per Equity Share

*From (L-R)*

Dilip Bidani, Group Chief Financial Officer, Paras Healthcare Limited

Dr. Dharminder Kumar Nagar, Managing Director, Paras Healthcare Limited

The Floor Price is 660 times, and the Cap Price is 693 times of the face value (₹1 per share) of the Equity shares

Bid/Offer will open on Wednesday, October 21, 2026, and close on Friday, October 23, 2026 (“Bid Dates”)

The Anchor Investor Bid/Offer Period shall be on Monday, October 19, 2026

Bids can be made for a minimum of 21 Equity Shares and in multiples of 21 Equity Shares thereafter (“No. of Bids”)

RHP Link: https://www.jmfl.com/Common/getFile/6104 

October 15, 2026: Paras Healthcare Limited (the “Company”), shall open the Bid/Offer in relation to its initial public offer (the “Offer”) of Equity shares on Wednesday, October 21, 2026.

 The price band of the Offer has been fixed at ₹ 660 to ₹ 693 per Equity Share. (“Price Band”).

Bids can be made for a minimum of 21 Equity Shares and in multiples of 21 Equity Shares thereafter. (“Minimum Bid Lot”).

The Anchor Investor Bidding Date shall be Monday, October 19, 2026. The Bid/Offer shall open on Wednesday, October 21, 2026.    

The Offer comprises a fresh issue of equity shares aggregating up to ₹ 500 crore and an offer for sale of equity shares aggregating up to ₹ 950 crore by the selling shareholder. The total offer size is up to ₹ 1450 crore. The face value of each equity share is ₹ 1.  

The Equity Shares of face value of ₹1 each to be offered through the Red Herring Prospectus are proposed to be listed on the stock exchanges being BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with the BSE, the “Stock Exchanges”). 

The Company proposes to utilize the net proceeds towards: 

Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by the company;

Investment in the wholly owned subsidiary, Plus Medicare Hospitals Private Limited (“PMHPL”) (which also operates its hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL and;

General corporate purposes

JM Financial Limited, BofA Securities India Limited and Nuvama Wealth Management Limited are the book running lead managers to the issue. 

*From L-R*

Yogesh Hede, Executive Director, JM Financial Limited

Dilip Bidani, Group Chief Financial Officer, Paras Healthcare Limited

Dr. Dharminder Kumar Nagar, Managing Director, Paras Healthcare Limited

Sayantan Bhattacharyya, Associate, BofA Securities India Limited

Priti Sahay, Director Healthcare & Pharma, Nuvama Wealth Management Limited

This is an Offer in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (the “SCRR”), read with Regulation 31 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). This Offer is being made through the Book Building Process in compliance with Regulation 6(2) of the SEBI ICDR Regulations, wherein at least 75% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs” and such portion, the “QIB Portion”), provided that our Company in consultation with the BRLMs, may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis, in accordance with SEBI ICDR Regulations (the “Anchor Investor Portion”), out of which 40% of the Anchor Investor Portion shall be reserved as follows: (i) 33.33% for domestic Mutual Funds; and (ii) 6.67% shall be available for allocation to Life Insurance Companies and Pension Funds, subject to valid Bids being received from the domestic Mutual Funds and Life Insurance Companies and Pension Funds at or above the price at which allocation will be made to Anchor Investors (“Anchor Investor Allocation Price”), in accordance with the SEBI ICDR Regulations and any under-subscription of 6.67% of the Anchor Investor Portion reserved for Life Insurance Companies and Pension Funds, may be allocated to domestic Mutual Funds. In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the remaining QIB Portion (the “Net QIB Portion”). 

Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders including Mutual Funds, subject to valid Bids being received at or above the Offer Price. If at least 75% of the Offer cannot be Allotted to QIBs, then the entire application money will be refunded forthwith. However, if the aggregate demand from Mutual Funds is less than 5% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. 

Further, not more than 15% of the Offer shall be available for allocation to Non-Institutional Bidders (“NIBs”) in accordance with the SEBI ICDR Regulations of which (a) one-third portion shall be reserved for applicants with application size of more than ₹200,000 and up to ₹1,000,000; and (b) two-thirds portion shall be reserved for applicants with application size of more than ₹1,000,000, provided that the unsubscribed portion in either of such sub-categories may be allocated to applicants in the other sub-category of Non-Institutional Bidders, subject to valid Bids being received at or above the Offer Price and not more than 10% of the Offer shall be available for allocation to Retail Individual Bidders (“RIBs”) in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. All Bidders (except Anchor Investors) are mandatorily required to utilise the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA accounts and UPI ID in case of UPI Bidders using the UPI Mechanism, in which case the corresponding Bid Amounts will be blocked by the SCSBs or by the Sponsor Banks, as applicable under the UPI Mechanism, to participate in the Offer. Anchor Investors are not permitted to participate in the Offer through the ASBA process

Disclaimer:

Paras Healthcare Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its equity shares and has filed a red herring prospectus dated October 14, 2026 (“RHP”) with the Registrar of Companies, Haryana at Chandigarh. The RHP is available on the website of SEBI at www.sebi.gov.in, the Company at www.parashospitals.com and the websites of the Book Running Lead Managers - JM Financial Limited, BofA Securities India Limited, Nuvama Wealth Management Limited at www.jmfl.com, https://business.bofa.com/bofas-india and www.nuvama.com, respectively and the websites of BSE Limited and National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com, respectively.

Investors should note that investment in equity shares involves a high degree of risk and for details refer to the RHP, including the section titled “Risk Factors”. Potential investors should not rely on the draft red herring prospectus for any investment decision.

The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) in the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to the private placement exemption set out in Section 4(a) of the U.S. Securities Act, and (b) outside the United States in “offshore transactions” as defined in and in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdictions where those offers and sales are made.

*‘कोण होणार करोडपती’: ‘फास्टेस्ट फिंगर फर्स्ट’ जिंकताच माधुरींच्या चाहत्याचा जल्लोष, ब्लेझर काढून केला डान्स!*

 

**कोण होणार करोडपती’: ‘फास्टेस्ट फिंगर फर्स्ट’ जिंकताच माधुरींच्या चाहत्याचा जल्लोष, ब्लेझर काढून केला डान्स!*

टी-शर्टवर माधुरी दीक्षित यांचा फोटो आणि समोर प्रत्यक्ष माधुरी! जळगावच्या शरद राजपूत यांच्यासाठी आपल्या लाडक्या अभिनेत्रीसमोर हॉट सीटवर बसण्याची संधी म्हणजे स्वप्नपूर्तीच. ‘कोण होणार करोडपती’च्या पहिल्या स्पर्धकाची झलक दाखवणाऱ्या या व्हिडिओमध्ये त्यांचा आनंद पाहण्यासारखा आहे. ‘फास्टेस्ट फिंगर फर्स्ट’ जिंकताच शरद यांनी चक्क ब्लेझर काढला आणि सेटवर नाचत जल्लोष केला! त्याच वेळी त्यांच्या टी-शर्टवरचा माधुरींचा फोटोही झळकला!

या भागातील आणखी एक मनोरंजक क्षण म्हणजे जेव्हा माधुरीने शरद यांना त्यांच्या पत्नीबद्दल बोलतं केलं. त्यावर शरद हसून म्हणाले, "ती माझं सगळं ऐकते." हे ऐकून माधुरीने लगेचच फिरकी घेत विचारले, "ती फक्त ऐकते की कधीकधी ऐकवते देखील?" माधुरीचा हा मिश्किल प्रश्न ऐकून संपूर्ण सेटवर एकच हशा पिकला.

कोण होणार करोडपती या शोमधून  माधुरी आता सूत्रसंचालकाच्या भूमिकेत येत असून, प्रेक्षकांना तिच्या चाहत्यांसोबतच्या अशाच दिलखुलास गप्पा, भावूक करणाऱ्या कथा आणि अविस्मरणीय क्षण पाहायला मिळणार आहेत.

माधुरींच्या सूत्रसंचालनात रंगणाऱ्या या नव्या पर्वात प्रेक्षकांना अशाच मनमोकळ्या गप्पा, मनाला भिडणारे अनुभव आणि चाहत्यांसोबतचे अविस्मरणीय क्षण पाहायला मिळणार आहेत.

पाहा ‘कोण होणार करोडपती’, १२ ऑक्टोबरपासून सोमवार ते शनिवार रात्री ९ वाजता, सोनी मराठी आणि Sony LIV वर.

https://www.instagram.com/reel/DeA_YSAjW7Y/?stkn=MTgwOThvdXVkN3FhYw==

गुरुकुल सायंस क्लासेज में विद्यार्थी विकास कार्यक्रम संपन्न

गुरुकुल सायंस क्लासेज में विद्यार्थी विकास कार्यक्रम संपन्

           “विद्यार्थी विकास ही देश का विकास है”                                       प्रो. डॉ. दिनेश गुप्ता आनंदश्री

महात्मा गांधी एवं लाल बहादुर शास्त्री जी की जयंती के अवसर पर कल्याण स्थित वैभव ठाकरे सर द्वारा संचालित गुरुकुल सायंस क्लासेज में विद्यार्थी विकास कार्यक्रम का आयोजन भाग्यश्री ठाकरे मैम के नेतृत्व में संपन्न हुआ। कार्यक्रम में मार्गदर्शक के रूप में माइंडसेट गुरु प्रो. डॉ. दिनेश गुप्ता आनंदश्री आमंत्रित थे। उन्होंने विद्यार्थियों को सफलता के पांच महत्त्वपूर्ण सूत्र बताते हुए कहा कि स्पष्ट लक्ष्य, सकारात्मक सोच, अनुशासन, निरंतर अभ्यास और आत्मविश्वास सफलता की कुंजी हैं। उन्होंने कहा, “विद्यार्थी विकास ही देश का विकास है।” विद्यार्थियों को अपनी क्षमताओं को पहचानने और जीवन में निरंतर आगे बढ़ने के लिए प्रेरित किया।

कार्यक्रम में विद्यार्थियों के साथ-साथ अभिभावकों ने भी उत्साहपूर्वक सहभागिता की। प्रो. डॉ. दिनेश गुप्ता आनंदश्री ने अभिभावकों को बच्चों की प्रतिभा पहचानने, उनका आत्मविश्वास बढ़ाने और उनके सर्वांगीण विकास में सहयोग देने का संदेश दिया। महात्मा गांधी के सत्य एवं अहिंसा और लाल बहादुर शास्त्री जी के सादगी एवं कर्तव्यनिष्ठा के आदर्शों से प्रेरणा लेते हुए विद्यार्थियों को जिम्मेदार नागरिक बनने के लिए प्रोत्साहित किया गया। यह कार्यक्रम विद्यार्थियों के व्यक्तित्व विकास, सकारात्मक सोच और जीवन-मूल्यों को मजबूत करने की दिशा में प्रेरणादायी रहा।

Prestigious Asia’s Modern Hero Award 2026

 Prestigious Asia’s Modern Hero Award 2026

Dr. Nilesh Potdar Honoured with Asia’s Modern Hero Award 2026

Renowned neurosurgeon Dr. Nilesh Potdar, Director of Mercury Hospital, Thane and surgeon at Galaxy Super speciality Hospital, has been awarded the prestigious Asia’s Modern Hero Award 2026 in Manila, Philippines. The award was presented on 25 September 2026 at Okada Manila by the Employers Confederation of the Philippines (ECOP) President Dr. Sergio Ortiz-Luis Jr. and Czech Republic Ambassador Mr. Karel Heytse.

Dr. Potdar is widely respected for his expertise in complex brain and spine surgeries and his pioneering work in precision neurological treatment. His hallmark technique, endoscopic spine surgery, allows operations through a small incision, reducing pain, blood loss, and helping patients return quickly to normal life.

This recognition comes after he was listed among “Top 10 Prominent Neurosurgeons” by Silicon India Healthcare in 2025, highlighting his consistent contribution to advanced neurosurgical care. Neurosurgery is considered one of the toughest branches of medicine, demanding years of training, quick decision-making, and constant innovation. Dr. Potdar’s success shows how modern technology and surgical skill together can deliver life-changing results.

Dr. Nilesh Potdar, Director of Mercury Hospital, Thane and Neurosurgeon at Galaxy Super speciality Hospital said,“Accurate treatment is my goal. This honour inspires me to do even better. "His dedication has not only brought pride to Mercure Hospital and Galaxy Super speciality Hospital but also strengthened access to advanced brain and spine care for patients in Thane and beyond. With compassion, precision, and innovation, Dr. Nilesh Potdar stands as an inspiration for the medical fraternity and a beacon of hope for patients across Asia.''

Inox Clean Energy Limited files DRHP with SEBI for Rs. 10,000 Crore IPO, set to be the largest in the Indian private sector renewable energy space

Inox Clean Energy Limited files DRHP with SEBI for Rs. 10,000 Crore IPO, set to be the largest in the Indian private sector renewable energy space

DRHP Link: https://www.nuvama.com/wp-content/uploads/2026/09/Inox-Clean-Energy-Limited-DRHP.pdf.

  

Inox Clean Energy Limited, part of the broader INOXGFL Group and a leading integrated renewable energy platform, has filed its DRHP with SEBI for an IPO.

The IPO of total issue size aggregating up to Rs. 10,000 Crore comprises of a fresh issue of up to Rs. 8,000 Crore and an offer for sale of up to Rs. 2,000 Crore by the selling shareholder.

Devansh Jain And Avarna Jain are the promoters of the company.

The proceeds from the fresh issue will be utilised towards repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and/or certain of its Subsidiaries (direct and indirect); and general corporate purposes.

Inox Clean Energy Limited is an integrated renewable energy platform with two principal business verticals, its renewable power generation business, which it undertake as an independent power producer the “IPP Business”, comprising an aggregate renewable IPP portfolio of 9.29 GW across India and Africa, of which 2.37 GW is operational and approximately 0.80 GW is under construction, 2.99 GW is pipeline capacity and 3.13 GW is future capacity, as of August 31, 2026. Its solar manufacturing business, under which it currently manufacture solar photovoltaic (PV) modules, with solar cell manufacturing capacity under construction in India and the United States, with an aggregate operational solar module manufacturing capacity of 6.00 GW across India and the United States, as of August 31, 2026. 

It is among the top 10 Indian renewable IPP platforms and, on a fully commissioned basis, among the top 10 Indian integrated solar PV module and cell manufacturing players, as of August 31, 2026, as per CRISIL Report. Company’s IPP Business comprises the development, acquisition, ownership and operation of renewable power generation assets, while the Solar Manufacturing Business comprises the manufacturing of PV modules for the renewable energy market, with backward integration into solar cell manufacturing currently under development.

In the IPP Business, It is the fastest scaled-up platform in India, having reached 2.37 GW of operational capacity within the past 1.5 years, since April 2025, through an active acquisition-led strategy, as per CRISIL Report.

The company represent a differentiated dual-engine renewable energy platform, uniquely combining scalable manufacturing revenues from its Solar Manufacturing Business with long-term annuity cash flows from its IPP Business, as per CRISIL Report. The company is one of the leading and among the few Indian-origin renewable energy platforms with an operational presence across three continents, operating renewable power generation platforms across India and, through SkyPower MENA, Africa, and its solar manufacturing facilities across India and the United States of America, as per CRISIL Report.

The Company is part of the broader INOXGFL Group, a diversified industrial group with businesses across chemicals and renewable energy and three listed entities in India, namely Gujarat Fluorochemicals Limited, Inox Wind Limited and Inox Green Energy Services Limited. The renewable energy platform benefits from the integrated capabilities of the INOXGFL Group ecosystem, spanning solar module manufacturing to IPP power generation, with access to wind turbine generators through Inox Wind Limited, engineering, procurement and construction capabilities through Inox Renewable Solutions Limited and renewable energy operations and maintenance through Inox Green Energy Solutions Limited, which as of August 31,2026 serviced O&M for 0.53 GW of its aggregate operational IPP capacity of approximately 2.37 GW.

It undertakes the IPP Business in India through Inox Neo Energies Limited and in Africa through SkyPower Services MENA Limited which is company’s venture with Arctic International Private Limited, its strategic partner. The company undertakes Solar Manufacturing Business in India through Inox Solar Limited while the solar module manufacturing operations in the United States are conducted through Inox Solar Americas LLC, a wholly owned subsidiary of Amura Renewables Private Limited.

Nuvama Wealth Management Limited, CLSA India Private Limited, Emirates NBD Capital India Private Limited, HSBC Securities and Capital Markets (India) Private Limited, ICICI Securities Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited), JM Financial Limited, Motilal Oswal Investment Advisors Limited, and UBS Securities India Private Limited are the book running lead managers to the offer.

*HPCL Hosts Mumbai Parallel Curtain Raiser of India Energy Week 2027 at S.P. Jain Institute of Management &Research (SPJIMR)*

 *HPCL Hosts Mumbai Parallel Curtain Raiser of India Energy Week 2027 at S.P. Jain Institute of Management &Research (SPJIMR)*

HPCL’s senior leadership at the India Energy Week 2027 curtain raiser in Mumbai.

• 380+ students from colleges across Mumbai engaged with the industry leaders, academia, start-ups and energy sector stakeholders

• Programme highlighted India’s energy transition, energy security, innovation and opportunities for young talent

*Mumbai, September 30, 2026:* Hindustan Petroleum Corporation Limited (HPCL) hosted the Mumbai Parallel Curtain Raiser of India Energy Week (IEW) 2027 at the S.P. Jain Institute of Management & Research (SPJIMR), bringing together students, academia, industry, government representatives and start-ups to engage with India’s evolving energy landscape.

The Mumbai programme was connected live with the national IEW 2027 Curtain Raiser in Kolkata, where the fifth edition of India Energy Week was formally announced under the theme “Unlocking Innovation. Securing Energy. Shaping Tomorrow.” The national Curtain Raiser was addressed by the Hon’ble Minister of Petroleum and Natural Gas Shri Hardeep Singh Puri and the Hon’ble Chief Minister of West Bengal Shri Suvendu Adhikari.

*The Mumbai event brought together Shri K S Shetty, Director- Human Resources, HPCL* ; Smt. Srividya Venkataraman, Director- Finance, HPCL; Dr. Varun Nagaraj, Dean and Professor of Information Management and Analytics, SPJIMR; and Prof. B. N. Chaudhari, Principal, Sardar Patel Institute of Technology, Mumbai, along with government representatives, start-ups, industry stakeholders and more than 380 students from colleges across Mumbai.

*Addressing the gathering, Shri K S. Shetty, Director- Human Resources, HPCL, said:* “India's energy journey is at an important inflection point. As we move towards the vision of Viksit Bharat@2047 while progressing towards our net-zero commitment by 2070, we need of simultaneously ensure energy security, affordability and sustainability. India Energy Week provides an important platform for this conversation, bringing together global expertise, technology, investment and young talent to shape the energy systems that will power India's next phase of growth.”

*Smt. Srividya Venkataraman, Director- Finance, HPCL, highlighted* the importance of creating pathways for innovative technologies to move from ideas and prototypes towards pilots and industrial-scale deployment. Smt. Srividya Venkataraman, Director—Finance, HPCL, said: “The transition from an innovative idea of a technology that can operate at industrial scale requires more than funding; if requires access of expertise, infrastructure, pilot opportunities and an industry partner willing to lest and adopt new solutions. Initiatives such as MC and MC + ICNITE are important because they seek of bridge this gap by connecting deep-tech innovators with the energy industry.”

The programme provided 380+ students with first-hand exposure to India's energy sector and insights into energy security, energy transition, technology, innovation, entrepreneurship and policy. The interaction between senior industry leadership, academia, government representatives and start-ups also provided students an opportunity to understand the emerging opportunities within the energy ecosystem.

The Mumbai audience subsequently joined the national proceedings from Kolkata, witnessing the Curtain Raiser addressed by the Hon'ble Minister of Petroleum and Natural Gas and the Hon'ble Chief Minister of West Bengal, along with other distinguished dignitaries and energy-sector stakeholders. With IEW 2027 scheduled in Kolkata from January 28-31, 2027, the Curtain Raiser sets the stage for a wider dialogue on “Unlocking Innovation. Securing Energy. Shaping Tomorrow.”

*About HPCL:*

Hindustan Petroleum Corporation Limited (HPCL), incorporated on July 15, 1974, is a Maharatna Central Public Sector Enterprise (CPSE) and one of India's leading integrated refining and marketing companies. With interests spanning refining, marketing, distribution, research and development, and renewable energy, HPCL is committed to delivering safe, reliable, and sustainable energy solutions. Through innovation, operational excellence, and customer-centricity, HPCL continues to play a key role in strengthening India's energy security and supporting the nation's transition towards a cleaner and more sustainable energy future.